Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

NCT00098345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: ZD6474 (vandetanib)

Sponsor

Genzyme, a Sanofi Company